Naval Medical Logistics Command selects Leidos for critical research into warfighter operational readiness
(RESTON, Va.) Nov. 23, 2020 – Leidos (NYSE:LDOS), a FORTUNE® 500 science and technology leader, was recently awarded a cost-plus-fixed-fee contract by the Naval Medical Logistics Command. Through this contract, Leidos will continue to perform operational medicine and warfighter performance research for the Naval Health Research Center’s (NHRC) Operational Readiness Directorate. The single award indefinite delivery, indefinite quantity contract holds a maximum value of $82 million. It includes a 60-month period of performance. Work will primarily be performed at NHRC in San Diego, California.
“We are excited to continue our support of the Naval Health Research Center,” said Liz Porter, Leidos Health Group president.“ Through this contract Leidos will utilize our robust scientific and technical expertise to support important NHRC research. We are proud to do our part to improve lives and ensure our military personnel can perform at the highest levels.”
NHRC conducts core research in operational readiness, military health and infectious diseases. In the area of operational readiness, NHRC leverages scientific breakthroughs to optimize human performance, recovery and resilience and to prevent injuries. They also develop medical planning, logistics and decision support tools for the nation’s armed forces.
Through this contract, Leidos will continue to provide data-driven research modeling to support operational medicine. The modeling is designed to enhance medical decision tools for operational commanders, medical logisticians and field medical personnel. In addition, the Leidos team will continue to analyze warfighter performance with medical research, development, testing, evaluation and surveillance services. The research outcomes are intended to enhance mission readiness, warfighter resilience and rehabilitation strategies for Department of Defense personnel worldwide.
Human performance, resilience and service member wellbeing are key focus areas for Leidos Health. Learn more at leidos.com/human-performance.
Leidos is a Fortune 500® information technology, engineering, and science solutions and services leader working to solve the world’s toughest challenges in the defense, intelligence, homeland security, civil, and health markets. The company’s 38,000 employees support vital missions for government and commercial customers. Headquartered in Reston, Va., Leidos reported annual revenues of approximately $11.09 billion for the fiscal year ended January 3, 2020. For more information, visit www.Leidos.com.
Statements in this announcement, other than historical data and information, constitute forward-looking statements that involve risks and uncertainties. A number of factors could cause our actual results, performance, achievements, or industry results to be very different from the results, performance, or achievements expressed or implied by such forward-looking statements. Some of these factors include, but are not limited to, the risk factors set forth in the company’s Annual Report on Form 10-K for the period ended January 3, 2020, and other such filings that Leidos makes with the SEC from time to time. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof.